Every patient and every cancer is unique. Molecular profiling helps provide a targeted solution.
Learn More About Caris Molecular Profiling
Cancer Biomarkers
Biomarkers are molecules that indicate a normal or abnormal process occurring in your body and may be a sign of an underlying condition or disease.
Patient Education Videos
Below are several resources and tools that provide additional information about cancer and molecular profiling.
What’s in a Cell?
DNA, RNA and Proteins
Gene Expression
What Causes Cancer?
What Causes Cancer to Grow?
Why Order Molecular Profiling?
The Difference in Germline and Somatic Cells
How Chemotherapy Works
How Targeted Therapy Works
How Immunotherapy Works
The Difference Between Point and Frameshift Mutations
The Difference Between Primary and Metastatic Cancer
What is Gene Fusion?
Microsatellite Instability
Genomic Instability
What is Homologous Recombination Deficiency?
Aneuploidy
What is Molecular Artificial Intelligence?
How is Cancer Diagnosed?
Tumor Mutational Burden
The Difference Between Small Molecule and Large Molecule Drugs
What is IHC and How Does it Work?
What is NGS and How Does it Work?
I want people to know that molecular profiling is so important when you have cancer, to know what treatment options you have.”
Christie Bevington, Lung Cancer Survivor
Christie Bevington, Lung Cancer Survivor
Patient FAQs
Caris molecular profiling is comprehensive genomic testing designed to help your doctor determine the best treatment plan for you. Our comprehensive molecular profiling approach assesses biomarkers found in your blood or tissue to reveal a molecular blueprint to guide more precise and individualized treatment decisions. A Caris report is generated for each patient and may help your doctor personalize treatment specific to your sample.
Caris molecular profiling uses multiple profiling technologies to decode cancer and better understand the biology driving cell growth. The biomarker results, or molecular blueprint, from a sample may determine how you respond to cancer treatments or if you qualify for clinical trials.
The results of these tests reveal your sample’s specific molecular biomarkers or targets, which provide molecular insights to help doctors personalize treatment to your unique cancer. Caris reports help doctors:
• navigate among therapies with potential benefit
• avoid certain therapies with unlikely benefit
• identify clinical trials trial opportunities
The report is a tool that provides a molecular blueprint to help your physician evaluate and guide more precise and individualized treatment decisions. You and your physician will determine your treatment plan, which will be based on many factors that may include the report, availability of cancer therapeutics, medical history and other clinical factors.
Yes, the report identifies clinical trial opportunities that are currently enrolling patients based on the unique biomarkers in your sample. Your physician will determine if any of these trials may be right for you.
A tissue or blood sample is collected either during a routine blood draw, during a biopsy, or during the surgical removal of your tissue. Your physician may wish to obtain a more recent sample from you as biomarkers may change over time and with treatment.
Caris molecular testing is performed in Phoenix, Arizona. Our state-of-the-art laboratories meet and exceed industry standards (CLIA, CAP, ISO 15189 and NY State approved/certified) and are staffed by a team of medical doctors, scientists and licensed technologists.
Once our laboratory receives your specimen and required documentation, results will be delivered directly to your physician for review in typically less than two weeks.
Caris will bill your insurance company directly as an independent service provider and work directly with them to process claims. Insurance companies usually take 60-90 days to respond to claims from Caris. You may receive an Explanation of Benefits (EOB) during this time, but this is NOT a bill. According to the terms of your healthcare plan, a bill for the deductible, co-insurance, or co-payment may be sent once the insurance company has processed the claim.
Share Your Molecular Profiling Story
Have you or a loved one received molecular profiling from Caris? If so, we’d love to hear about your cancer journey and how molecular profiling played a role. Your story may provide strength and support to others who are battling cancer.
Discover
More
Are you looking for an oncologist with expertise in molecular profiling? Caris Life Sciences maintains a database of physicians who have previously ordered Caris molecular profiling offerings.
We remain focused on the most important part of our work – the patient. Hear from those who courageously share their cancer journey including Caris molecular profiling, offering valuable insights and perspectives that go beyond the statistics and outcomes.